Question 1

What are the potential benefits and risks of adjuvant nivolumab or pembrolizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery clinical trial (NCT03843593). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my decision impact my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery clinical trial (NCT03843593). Contact the study team or your healthcare provider for specific answers.

Question 3

What factors should I consider when deciding on adjuvant therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery clinical trial (NCT03843593). Contact the study team or your healthcare provider for specific answers.

Question 4

Can you explain how this trial's findings might help me with my treatment choices?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery clinical trial (NCT03843593). Contact the study team or your healthcare provider for specific answers.

Question 5

What support will I have in making my treatment decision?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery clinical trial (NCT03843593). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my quality of life be monitored during and after treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery clinical trial (NCT03843593). Contact the study team or your healthcare provider for specific answers.

What this study is about